Natco Pharma and Lupin gained FDA approval for bioequivalent generic eribulin mesylate injection, potentially reducing ...

Cancer Res (1968) 28 (5): 811–822. A large cooperative study to obtain quantitative information about the use of cyclophosphamide and the vinca alkaloids as therapeutic agents in patients with ...

Stroke is a life-threatening event in which part of the brain does not receive enough oxygen, usually because of a blood clot blocking an artery in the brain. Stroke is the third leading cause of ...

Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy among patients with cancer. Neuromuscular training, including sensorimotor training (SMT) and whole-body ...

St. Jude Children's Research Hospital scientists have identified specific DNA variants in the non-coding regions of the genome contributing to chemotherapy resistance in acute lymphoblastic leukemia ...

A recent, bizarre murder case in Minnesota involved a physician (a poison expert) accused of poisoning his wife with a toxic gout drug called colchicine. The fact that she didn’t have gout, and that ...

Over the years, many biological and synthetic agents have been explored and tested in attempts to halt the spread of cancer and/or cure it. Currently, several natural compounds have and are being ...